John F. Neylan insider trades: Angion Biomedica (ANGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
32 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | ANGN | ↓ Sell | 358 | $2.62 | $938 | Direct | Dec 21, 2021 (1d) |
| Nov 18, 2021 | ANGN | ↓ Sell | 374 | $4.13 | $2K | Direct | Nov 22, 2021 (4d) |
| Oct 18, 2021 | ANGN | ↓ Sell | 373 | $8.62 | $3K | Direct | Oct 20, 2021 (2d) |
| Sep 20, 2021 | ANGN | ↓ Sell | 376 | $10.07 | $4K | Direct | Sep 21, 2021 (1d) |
| Aug 18, 2021 | ANGN | ↓ Sell | 381 | $9.03 | $3K | Direct | Aug 19, 2021 (1d) |
| Jul 21, 2021 | ANGN | ↓ Sell | 365 | $10.98 | $4K | Direct | Jul 22, 2021 (1d) |
| Jun 18, 2021 | ANGN | ↓ Sell | 366 | $13.20 | $5K | Direct | Jun 21, 2021 (3d) |
| May 18, 2021 | ANGN | ↓ Sell | 363 | $13.91 | $5K | Direct | May 19, 2021 (1d) |
| Apr 19, 2021 | ANGN | ↓ Sell | 381 | $13.55 | $5K | Direct | Apr 20, 2021 (1d) |
| Mar 17, 2021 | ANGN | ↓ Sell | 442 | $19.13 | $8K | Direct | Mar 19, 2021 (2d) |
| Nov 15, 2018 | KERX | ↓ Sell | 1,156 | $2.77 | $3K | Direct | Nov 16, 2018 (1d) |
| Oct 29, 2018 | KERX | ↓ Sell | 1,253 | $3.07 | $4K | Direct | Oct 30, 2018 (1d) |
| Aug 15, 2018 | KERX | ↓ Sell | 1,186 | $3.04 | $4K | Direct | Aug 16, 2018 (1d) |
| Jul 30, 2018 | KERX | ↓ Sell | 1,282 | $3.86 | $5K | Direct | Jul 31, 2018 (1d) |
| May 15, 2018 | KERX | ↓ Sell | 1,158 | $5.69 | $7K | Direct | May 16, 2018 (1d) |
| Apr 30, 2018 | KERX | ↓ Sell | 1,311 | $4.67 | $6K | Direct | May 1, 2018 (1d) |
| Apr 23, 2018 | KERX | ↓ Sell | 1,111 | $4.59 | $5K | Direct | Apr 24, 2018 (1d) |
| Feb 15, 2018 | KERX | ↓ Sell | 5,652 | $4.81 | $27K | Direct | Feb 16, 2018 (1d) |
| Jan 29, 2018 | KERX | ↓ Sell | 1,541 | $4.81 | $7K | Direct | Jan 31, 2018 (2d) |
| Jan 23, 2018 | KERX | ↓ Sell | 1,322 | $4.92 | $7K | Direct | Jan 24, 2018 (1d) |
| Oct 30, 2017 | KERX | ↓ Sell | 1,405 | $6.03 | $8K | Direct | Oct 31, 2017 (1d) |
| Oct 23, 2017 | KERX | ↓ Sell | 1,179 | $6.53 | $8K | Direct | Oct 24, 2017 (1d) |
| Jul 31, 2017 | KERX | ↓ Sell | 1,445 | $7.14 | $10K | Direct | Aug 1, 2017 (1d) |
| Jul 24, 2017 | KERX | ↓ Sell | 1,214 | $7.27 | $9K | Direct | Jul 25, 2017 (1d) |
| May 1, 2017 | KERX | ↓ Sell | 1,441 | $5.97 | $9K | Direct | May 3, 2017 (2d) |
| Apr 24, 2017 | KERX | ↓ Sell | 1,209 | $5.73 | $7K | Direct | Apr 26, 2017 (2d) |
| Jan 30, 2017 | KERX | ↓ Sell | 6,984 | $4.65 | $32K | Direct | Jan 31, 2017 (1d) |
| Jan 23, 2017 | KERX | ↓ Sell | 1,428 | $5.39 | $8K | Direct | Jan 25, 2017 (2d) |
| Oct 24, 2016 | KERX | ↓ Sell | 1,211 | $4.72 | $6K | Direct | Oct 25, 2016 (1d) |
| Jul 25, 2016 | KERX | ↓ Sell | 1,217 | $7.43 | $9K | Direct | Jul 27, 2016 (2d) |
| Apr 25, 2016 | KERX | ↓ Sell | 4,766 | $5.21 | $25K | Direct | Apr 27, 2016 (2d) |
| Aug 12, 2015 | KERX | ↑ Buy | 10,000 | $6.20 | $62K | Direct | Aug 14, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John F. Neylan's insider trades
John F. Neylan is See Remarks at Angion Biomedica (ANGN). Since Aug 12, 2015, John has reported 1 open-market purchase worth $62K and 31 sales worth $246K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.